or
forgot password


Phase 2
18 Years
N/A
Not Enrolling
Both
Urologic Neoplasms, Metastases, Neoplasm

Thank you

Trial Information


Inclusion Criteria:



- You must have been diagnosed with bladder cancer that has recurred or moved to a new
part of the body.

- You must have at least one tumor that can be physically measured or scanned by x-ray.

- You may not have had previous chemotherapy (drug) treatment OR you have had surgery
followed by one chemotherapy treatment at least 4 months ago.

Exclusion Criteria:

- You may not have used an experimental medicine or device within the past month.

- Cancer that has spread to your brain.

- If you are unwilling or unable to take folic acid or vitamin B12 supplements.

Type of Study:

Interventional

Study Design:

Primary Purpose: Treatment

Authority:

United States: Food and Drug Administration

Study ID:

4698

NCT ID:

NCT00035061

Start Date:

Completion Date:

Related Keywords:

  • Urologic Neoplasms
  • Metastases, Neoplasm
  • Bladder Cancer
  • Metastatic
  • Recurrent
  • Transitional cell carcinoma of the urothelium
  • Neoplasms
  • Carcinoma, Transitional Cell
  • Neoplasm Metastasis
  • Urologic Neoplasms

Name

Location

Hinsdale, Illinois  60521
Fountain Valley, California  92708
Miami, Florida  33176
Cleveland, Ohio  44195
Philadelphia, Pennsylvania  19104
Nashville, Tennessee  37203-1632
Austin, Texas  78705
Seattle, Washington  98195
Louisville, Kentucky  40207
Kansas City, Kansas  66160
Omaha, Nebraska  68114
Boston, Massachusetts  
Indianapolis, Indiana